A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected Adults

Completed · Phase 1 · Has a placebo group

Conditions studied: Hepatitis C

In brief

To evaluate the safety, tolerability and pharmacokinetics of ABT-072 in healthy volunteers and its anti-viral activity in HCV infected subjects.

Key facts

Study ID
NCT00752687
Run by
Abbott
People needed
100
Starts
2008-09-01
Last updated by the study team
2010-10-21

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.